SCHEMBL5775787

SCHEMBL5775787

CN(Cc1csc(/C=N/Nc2ccc(-c3cn4cc(I)ccc4n3)cc2)n1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.42
ALDH1A1 P00352 9/20 0.37
KDM4E B2RXH2 8/20 0.37
NPC1 O15118 7/20 0.37
SMN1; SMN2 Q16637 6/20 0.37
RAB9A P51151 6/20 0.37
POLB P06746 5/20 0.37
HPGD P15428 3/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
MAPT P10636 3/20 0.35
KMT2A Q03164 2/20 0.35
HTT P42858 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MCHR1 Q99705 2/20 0.33
ALDH1A3 P47895 1/20 0.33
GAA P10253 2/20 0.33
PKM P14618 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5775791 1.00 APP (0.42) APPALDH1A1KDM4ENPC1SMN1; SMN2
SCHEMBL5775797 0.85 ALDH1A1 (0.38) APPALDH1A1KDM4ENPC1SMN1; SMN2
SCHEMBL5773610 0.84 APP (0.43) APPALDH1A1KDM4ENPC1SMN1; SMN2
SCHEMBL5780438 0.77 APP (0.43) APPALDH1A1KDM4ENPC1SMN1; SMN2
SCHEMBL5774837 0.74 IMPDH2 (0.39) ALDH1A1KDM4ENPC1RAB9APOLB
SCHEMBL5778995 0.70 CLK1 (0.44) APPALDH1A1KDM4ENPC1SMN1; SMN2
SCHEMBL5778998 0.70 CLK1 (0.44) APPALDH1A1KDM4ENPC1SMN1; SMN2
SCHEMBL5775433 0.69 RAB9A (0.49) APPALDH1A1KDM4ENPC1SMN1; SMN2
SCHEMBL5778186 0.69 APP (0.46) APPALDH1A1KDM4ENPC1SMN1; SMN2
SCHEMBL5778184 0.69 APP (0.46) APPALDH1A1KDM4ENPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276433-A1 Hydrazone derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-12-07 US disclosed
EP-1612204-A1 HYDRAZONE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276433-A1 Hydrazone derivative APP, PRNP, HTT APP 1/4885ALDH1A1 1541/4885KDM4E 4325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.